Thomas H. Glocer
• Member of the Supervisory Board
• Member of Compensation Committee
• Member of the Strategy and Risk Committee
Biography
Thomas H. Glocer was a corporate lawyer within the Davis Polk & Wardwell law firm before joining Reuters in 1993. He was appointed Chair and CEO of Reuters Group in 2001 and then from April 2008 to December 2011, Chair and CEO of Thomson Reuters Corp. He is currently Executive Chair of BlueVoyant LLC and Capitolis Inc., specializing respectively in cyberdefense and financial technology. He was also General Partner in Communitas Capital LLC, a venture capital company and member of the Board of Directors of Morgan Stanley and of Merck & Co.
Other offices and positions held within the Group
None
Main offices and positions held outside the Group
• Founder and Managing Partner: Angelic Ventures LP (United States)
• Executive President: Capitolis, Inc. (United States), BlueVoyant LLC (United States)
• Director: Merck &Co., Inc., listed company (United States), Morgan Stanley, listed company (United States), K2 Intelligence, Inc. (United States), Reynen Court LLC (United States), Atlantic Council (United States), Ensign Global (United Kingdom)
• General Partner: Communitas Capital LLC (United States)
• Member of the Board of Trustees: Cleveland Clinic (United States)
• Member: President’s Council on International Activities at Yale University (United States), European Business Leaders Council – EBLC – (Finland)
• Member of the Advisory Committee: Columbia Global Center, Paris (United States)
• Member of the International Advisory Group: Linklaters LLP (United Kingdom)
Offices and positions held outside the Group in the last five years
Positions listed above as well as the following offices:
• Director: Adfin Solutions (United States) (term expired in May 2016), Council on Foreign Relations (United States) (term expired in July 2016)